Literature DB >> 1463180

Anaesthetic experience with cryotherapy for treatment of hepatic malignancy.

D B Goodie1, M D Horton, R W Morris, L S Nagy, D L Morris.   

Abstract

Hepatic cryotherapy is a relatively new technique, currently employed in the treatment of unresectable liver malignancy, which involves direct freezing of tumour deposits with liquid nitrogen. In a review of 26 patients undergoing this procedure, the anaesthetic considerations are defined. The total operation time ranged from 133 to 410 minutes. In spite of preventative measures, varying degrees of hypothermia occurred (range 33.7 degrees C to 36.5 degrees C), but no sequelae were encountered. Mean blood loss was 926 ml, and eleven patients required blood transfusion of between one and five units. There was a marked drop in platelet count associated with cryotherapy (mean fall of 123,000/mm3 by the second postoperative day). Following the procedure, fever and basal pulmonary atelectasis were common, while hypoglycaemia and renal impairment occurred on single occasions. Six patients underwent postoperative mechanical ventilation. Despite this, the mean hospital stay was under seven days.

Entities:  

Mesh:

Year:  1992        PMID: 1463180     DOI: 10.1177/0310057X9202000418

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  7 in total

1.  Perductal electrolytic ablation of the porcine pancreas: a minimally invasive option-studies of morbidity and mortality.

Authors:  C P Morrison; F G Court; S A Wemyss-Holden; B D Teague; A Burrell; M Texler; M S Metcalfe; A R Dennison; G J Maddern
Journal:  Surg Endosc       Date:  2004-08-24       Impact factor: 4.584

2.  Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion.

Authors:  D L Morris; M D Horton; A V Dilley; A Warlters; P R Clingan
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

3.  Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model.

Authors:  Joachim K Seifert; Malcolm P France; Jing Zhao; Elaine J Bolton; Ian Finlay; Theodor Junginger; David L Morris
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

4.  Local platelet trapping as the cause of thrombocytopenia after hepatic cryotherapy.

Authors:  Georg A Pistorius; Christof Alexander; Carl-Martin Krisch; Gernot Feifel; Martin K Schilling; Michael D Menger
Journal:  World J Surg       Date:  2005-05       Impact factor: 3.352

5.  Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases.

Authors:  V Dasappa; W B Ross; J King; D W King; P R Clingan; D L Morris
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

6.  Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury.

Authors:  P J Cozzi; G J Stewart; D L Morris
Journal:  World J Surg       Date:  1994 Sep-Oct       Impact factor: 3.352

7.  Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy.

Authors:  A P Preketes; J R Caplehorn; J King; P R Clingan; W B Ross; D L Morris
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.